Hospital Universitario de Navarra;Unidad de Neuropediatría

Pamploa, Navarre 31008

0 studies enrolling now · 1 studies all time

What they study most

Angelman Syndrome

Studies at this site

• A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. — Completed